Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss the approval of a GLP-1 pill for weight ...

The new drug, simply called the Wegovy pill, marks a turning point in the modern weight-loss revolution. Until now, every ...

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...

It’s like a switch that goes on and you’re instantly starving.” Tanya Hall’s words capture a reality many face when they stop ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making ...

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to Regulations ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

Food and drink manufacturers in the US will open the door to the new year with a fresh challenge – the first pill variant of ...

Packaged food makers and fast-food chains are bracing for change as GLP-1 pills become available, following FDA approval of Novo Nordisk's Wegovy. The pills, expected to be cheaper than injections, ...

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...